Heparin-induced thrombocytopenia: an overview
- 1 March 2002
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 16 (1) , 77-80
- https://doi.org/10.1054/blre.2001.0189
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin)European Journal of Haematology, 2000
- Heparin-Induced ThrombocytopeniaDrugs & Aging, 2000
- Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopeniaPlatelets, 2000
- Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin InhibitorSeminars in Thrombosis and Hemostasis, 1997
- DanaparoidDrugs, 1997
- Anticoagulation with Novastan®(Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis SyndromeSeminars in Thrombosis and Hemostasis, 1997
- A 14-year study of heparin-induced thrombocytopeniaThe American Journal of Medicine, 1996
- Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assayTransfusion, 1994
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.Journal of Clinical Investigation, 1994
- Heparin-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 1976